There is significant interest inMRK by institutional investors. The 75.16% of outstanding shares they control represents a greater percentage of ownership than at any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended December 2017, these large investors purchased a net $13.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 14.1 Million shares of Merck & Co Inc
SUNAMERICA ASSET MANAGEMENT LLC Bought 8.3 Million shares of Merck & Co Inc
CITADEL ADVISORS LLC Bought 7.8 Million shares of Merck & Co Inc